Goldman Sachs’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-30,000	Closed	-$946K	–	5271
2020 Q1	$946K	Buy	+30,000	New	+$1.58M	﹤0.01%	3803
2019 Q1	–	Sell	-5,000	Closed	-$230K	–	5214
2018 Q4	$230K	Hold	5,000	–	–	﹤0.01%	4760
2018 Q3	$222K	Hold	5,000	–	–	﹤0.01%	4869
2018 Q2	$196K	Buy	+5,000	New	+$253K	﹤0.01%	4999
2018 Q1	–	Sell	-6,300	Closed	-$415K	–	6007
2017 Q4	$415K	Sell	6,300 -9,700	-61%	-$522K	﹤0.01%	4975
2017 Q3	$802K	Sell	16,000 -15,700	-50%	-$757K	﹤0.01%	4763
2017 Q2	$1.47M	Sell	31,700 -3,600	-10%	-$132K	﹤0.01%	4106
2017 Q1	$1.25M	Buy	35,300 +20,800	+143%	+$476K	﹤0.01%	4189
2016 Q4	$182K	Buy	14,500 +4,500	+45%	+$53.6K	﹤0.01%	5830
2016 Q3	$139K	Buy	10,000 +300	+3%	+$3.4K	﹤0.01%	6058
2016 Q2	$96K	Sell	9,700 -33,200	-77%	-$550K	﹤0.01%	6148
2016 Q1	$725K	Sell	42,900 -8,000	-16%	-$129K	﹤0.01%	4374
2015 Q4	$1.13M	Buy	50,900 +16,100	+46%	+$406K	﹤0.01%	4174
2015 Q3	$821K	Sell	34,800 -180,600	-84%	-$11.3M	﹤0.01%	4669
2015 Q2	$17.6M	Buy	215,400 +215,200	+107,600%	+$21.1M	0.01%	1889
2015 Q1	$19K	Buy	+200	New	+$12.9K	﹤0.01%	6904